Bearish flow noted in GSK (GSK) Pharma with 5,611 puts trading, or 3x expected. Most active are Mar-25 36.5 puts and 3/14 weekly 39.5 calls, with total volume in those strikes near 6,100 contracts. The Put/Call Ratio is 3.01, while ATM IV is up nearly 9 points on the day. Earnings are expected on April 30th.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GSK:
- ViiV announces new study data showing zero HIV cases with Apretude
- ViiV Healthcare announces data from EMBRACE Phase IIb study
- GSK Pharma put volume heavy and directionally bearish
- Trevi Therapeutics upgraded to Strong Buy from Outperform at Raymond James
- GSK announces U.S. FDA accepted for review BLA for depemokimab
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue